SOW
ALDX icon

State of Wyoming’s Aldeyra Therapeutics ALDX Stock Holding History

State of Wyoming’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,443
Closed -$12.1K – 1599
2023
Q2 		$12.1K Buy
+1,443
New +$14.2K ﹤0.01% 1469
2022
Q2 		– Sell
-1,114
Closed -$5K – 1851
2022
Q1 		$5K Buy
1,114
+19
+2% +$76 ﹤0.01% 1654
2021
Q4 		$4K Buy
1,095
+18
+2% +$137 ﹤0.01% 1730
2021
Q3 		$9K Buy
1,077
+645
+149% +$5.92K 0.01% 1037
2021
Q2 		$5K Buy
+432
New +$5.19K ﹤0.01% 1068

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

State of Wyoming's ALDX Position: Q3 2023 in Review

State of Wyoming sold out of Aldeyra Therapeutics (ALDX) in Q3 2023, closing a stake of 1,443 shares — an estimated $12.1K sold.

State of Wyoming first reported a position in ALDX in Q2 2021 and held it in 5 quarters. The position peaked at $12.1K in Q2 2023. 120 funds tracked by Wall St. Rank hold ALDX as of Q3 2023.

  • State of Wyoming reported no remaining Aldeyra Therapeutics position as of Q3 2023 after selling out during the quarter.
  • State of Wyoming sold 1,443 Aldeyra Therapeutics shares in Q3 2023, an estimated $12.1K.
  • State of Wyoming first reported a position in Aldeyra Therapeutics in Q2 2021 and held it in 5 quarters.
  • State of Wyoming's Aldeyra Therapeutics position peaked at $12.1K in Q2 2023.
  • 120 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2023.

Based on State of Wyoming's 13F filing for Q3 2023, filed 14 Nov 2023.